Related by context. Frequent words. (Click for all words.) 68 Marqibo 67 AP# [003] 67 MGCD# [001] 66 Phase Ib 66 picoplatin 65 INCB# [002] 65 FOLOTYN 65 MDV# 65 HspE7 65 perifosine 65 ZEVALIN 65 panitumumab 64 ofatumumab 64 pralatrexate 64 voreloxin 63 RG# [001] 62 Phase 2b study 62 T DM1 62 daclizumab 62 XL# [003] 62 Phase 2b clinical 62 Phase IIa clinical 62 IMGN# 62 ISIS # 62 anticancer agents 61 hematologic malignancies 61 ASA# 61 Phase 2b trial 61 CYT# 61 ADVEXIN 61 hematological malignancies 61 elesclomol 60 vilazodone 60 cutaneous T cell 60 Genasense 60 Phase 1b 60 carfilzomib 60 humanized monoclonal antibody 60 Phase IIa trial 60 LymphoStat B 60 myelofibrosis 60 CRx 60 PLX# 59 Homspera 59 Vidaza 59 gefitinib 59 APD# 59 Phase III clinical 59 solid tumors 59 dasatinib 59 ENMD 59 AEZS 59 satraplatin 59 ARRY 59 AZD# 59 linaclotide 59 PRX # 59 mipomersen 59 Phase IIb clinical 59 Albuferon 59 tamibarotene 59 hormone refractory prostate cancer 59 chemotherapeutic agents 59 dose escalation 59 nimotuzumab 58 dosing regimens 58 endocrine therapy 58 NSCLC 58 docetaxel 58 eculizumab 58 RDEA# 58 Phase 2b 58 tivozanib 58 BiovaxID 58 oritavancin 58 antitumor activity 58 FTY# 58 Zerenex 58 Rituximab 58 pivotal Phase III 58 Phase IIb trial 58 trastuzumab 58 Phase III clinical trials 58 VELCADE 58 NKTR 58 telbivudine 58 Phase 2a 58 Molecular Insight 58 bortezomib 58 clofarabine 58 Vectibix 58 ANA# 58 ISA# [002] 57 Phase 2a clinical 57 cetuximab 57 oral formulation 57 Phase IIb 57 sunitinib 57 immunotherapeutic 57 NovaDel 57 PROVENGE